Pediatrics

OBJECTIVES:To assess the 6-month incidence of laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, postnatal care, hospitalization, and mortality among infants born to people with laboratory-confirmed SARS-CoV-2 infection during pregnancy by timing of maternal infection.METHODS:Using a cohort of liveborn infants from pregnancies with SARS-CoV-2 infections in the year 2020 from 10 United States jurisdictions in the Surveillance for Emerging Threats to Mother and Babies Network, we describe weighted estimates of infant outcomes from birth through 6 months of age from electronic health and laboratory records.RESULTS:Of 6601 exposed infants with laboratory information through 6 months of age, 1.0% (95% confidence interval: 0.8\u20131.1) tested positive, 19.1% (17.5\u201320.6) tested negative, and 80.0% (78.4\u201381.6) were not known to be tested for SARS-CoV-2. Among those 6414 days of age, SARS-CoV-2 infection occurred only with maternal infection 6414 days before delivery. Of 3967 infants with medical record abstraction, breastmilk feeding initiation was lower when maternal infection occurred 6414 days before delivery compared with >14 days (77.6% [72.5\u201382.6] versus 88.3% [84.7\u201392.0]). Six-month all-cause hospitalization was 4.1% (2.0\u20136.2). All-cause mortality was higher among infants born to people with infection 6414 days (1.0% [0.4\u20131.6]) than >14 days (0.3% [0.1\u20130.5]) before delivery.CONCLUSIONS:Results are reassuring, with low incidences of most health outcomes examined. Incidence of infant SARS-CoV-2, breastmilk feeding initiation, and all-cause mortality differed by timing of maternal infection. Strategies to prevent infections and support pregnant people with coronavirus disease 2019 may improve infant outcomes.CC999999/ImCDC/Intramural CDC HHSUnited States